MX9803217A - Method of mobilizing hematopoietic stem cells. - Google Patents
Method of mobilizing hematopoietic stem cells.Info
- Publication number
- MX9803217A MX9803217A MX9803217A MX9803217A MX9803217A MX 9803217 A MX9803217 A MX 9803217A MX 9803217 A MX9803217 A MX 9803217A MX 9803217 A MX9803217 A MX 9803217A MX 9803217 A MX9803217 A MX 9803217A
- Authority
- MX
- Mexico
- Prior art keywords
- stem cells
- hematopoietic stem
- mobilizing hematopoietic
- gro
- mobilizing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/521—Chemokines
- C07K14/522—Alpha-chemokines, e.g. NAP-2, ENA-78, GRO-alpha/MGSA/NAP-3, GRO-beta/MIP-2alpha, GRO-gamma/MIP-2beta, IP-10, GCP-2, MIG, PBSF, PF-4, KC
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/193—Colony stimulating factors [CSF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/49—Platelet-derived growth factor [PDGF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Molecular Biology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Toxicology (AREA)
- Immunology (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Diabetes (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Physics & Mathematics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Hematology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
A method of mobilizing hematopoietic stem cells from the bone marrow to the peripheral circulation is provided by administering to an animal an effective amount of nature, modified or multimeric forms of KC, gro'beta', gro'alpha' or gro'gamma'.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US54726295A | 1995-10-24 | 1995-10-24 | |
US547262 | 1995-10-24 |
Publications (2)
Publication Number | Publication Date |
---|---|
MX9803217A true MX9803217A (en) | 1998-09-30 |
MXPA98003217A MXPA98003217A (en) | 1998-11-16 |
Family
ID=
Also Published As
Publication number | Publication date |
---|---|
ZA968896B (en) | 1997-04-24 |
NO981818D0 (en) | 1998-04-23 |
EP0866806A4 (en) | 2002-01-09 |
CZ120298A3 (en) | 1998-09-16 |
HUP9802531A2 (en) | 1999-02-01 |
PL326364A1 (en) | 1998-09-14 |
EP0866806A1 (en) | 1998-09-30 |
BR9611173A (en) | 1999-03-30 |
NZ321789A (en) | 2000-07-28 |
AU712235B2 (en) | 1999-11-04 |
JPH11512747A (en) | 1999-11-02 |
TR199800742T2 (en) | 1998-08-21 |
KR19990066997A (en) | 1999-08-16 |
WO1997015595A1 (en) | 1997-05-01 |
AU7520996A (en) | 1997-05-15 |
NO981818L (en) | 1998-06-17 |
HUP9802531A3 (en) | 2001-08-28 |
AR004093A1 (en) | 1998-09-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL72643A (en) | Gene encoding an analog of human interleukin-ii which substantially retains the biological activity of natural human interleukin-ii,microorganism expression vector containing the gene,microorganisms transformed by the vector and the human interleukin-ii analog produced by the microorganisms | |
ES8307263A1 (en) | Substituted phosphonamides, a process for preparing the same and a pharmaceutical composition which is useful in the treatment of hypertension. | |
AU6760987A (en) | Method of treating alzheimer's disease | |
ZA9810444B (en) | Use of 9-deoxy-2',9-methano-3-oxa-4,5,6-trinor-3,7-(1',3'interphenylene)-13,14-dihydroprostaglandin F1 to treat peripheral vascular disease | |
ES8900017A1 (en) | N,N-dialkylguanidino dipeptides. | |
ES8606289A1 (en) | Anti-virally active pyridazinamines. | |
GB8912330D0 (en) | Live vaccines | |
OA07021A (en) | Method of inclusion of microorganisms from the group of mycorrhizae and actinorrhizae. | |
BE1002196A3 (en) | BACTERIAL TREATMENT TO PROTECT THE QUALITY OF HAY BY ADDITION OF MICROORGANISMS OF THE GENUS BACILLUS. | |
IT1217828B (en) | FERMENTATION DEVICE FOR THE AEROBIC CULTURE OF MICROORGANISMS | |
HUT55613A (en) | Process for improving the fodder utilization of animals by the application of bacteriolysing enzymes and proteases | |
EP0139468A3 (en) | Hair treatment composition | |
EP0219782A3 (en) | Use of angiotensin-converting enzyme inhibitors in the treatment of atherosclerosis, thrombosis and peripheral vascular disease | |
NO981818L (en) | Procedure for Mobilizing Hematopoietic Stem Cells | |
EP0339163A3 (en) | Monoclonal antibodies specific for hiv and hybridomas for their production | |
GB9410639D0 (en) | Method of improving fertilization | |
ES8609461A1 (en) | Method and compositions for use in the treatment of fireblight. | |
ES8800725A1 (en) | Monoclonal antibodies to tissue plasminogen activator derived from human normal cells. | |
ES2038642T3 (en) | DERMIC TREATMENT OF VERMICULAR DISEASES OF THE CAT WITH PRACICUANTEL. | |
DE69625910D1 (en) | PENAMSULPHONES AS BETA LACTAMASE INHIBITORS | |
IT9022010A0 (en) | PROCEDURE FOR THE USE OF ORGANIC WASTE FOR THE PRODUCTION OF BIOGAS AND AGRICULTURAL PRODUCTS. | |
ES8706202A1 (en) | Use of efomycines for increasing the efficiency by animals, efomycines and their preparation. | |
ATE248218T1 (en) | HUMAN HYPERTROPHIC CHRONDROCYTE CELL LINES | |
IT1217825B (en) | PROCEDURE AND PLANT FOR THE CULTURE OF MICROORGANISMS | |
SE8601421L (en) | HAIR TREATMENTS AND PROCEDURES FOR COSMETIC TREATMENT OF HAIR AND RESIN |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |